CROX vs DKS: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: CROX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CROX and DKS share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CROX and DKS exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Crocs, Inc. designs and sells casual footwear under two brands. The Crocs Brand centers on its signature molded clog made from a proprietary closed-cell resin the company calls Croslite, extended through sandals, sneakers, and the Jibbitz charms that let buyers personalize their shoes. In 2022 Crocs acquired HEYDUDE, a lightweight casual-shoe brand, to add a second growth engine. The company sells through wholesale partners and a growing direct-to-consumer channel that includes its own websites and stores, and it markets heavily through collaborations and celebrity tie-ins. Crocs is known for operating margins well above most footwear peers (about 24% on a trailing basis, with gross margin near 57%), driven by a simple core product, strong pricing, and relatively low marketing spend versus sales.

Full CROX guide

Dick's Sporting Goods is the leading omnichannel sporting-goods retailer in the United States, offering athletic footwear, apparel, and equipment across roughly 850-plus stores plus a growing e-commerce business. Beyond its traditional big-box format, Dick's has invested in experiential concepts, most notably House of Sport (large, activity-rich stores with features like climbing walls and turf fields) and Public Lands (outdoor recreation), which it sees as the future of physical retail. Its brand relationships with Nike, Adidas, and others, plus strong private brands, give it merchandising strength, and it has generally outperformed many retail peers on comparable-sales growth and margins.

Full DKS guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CROX drivers: High-margin core Crocs Brand; Cash generation and share buybacks.
• DKS drivers: Core comparable-sales momentum; Experiential store formats.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The largest risk is that Crocs depends heavily on one iconic product, so a shift in fashion or a fading of the clog trend could hurt demand quickly, and single-product concentration makes the stock sensitive to sentiment about the brand's staying power. For DKS, the dominant near-term risk is Foot Locker integration: absorbing a large, mall-concentrated, historically lower-margin chain carries execution, margin-dilution, and turnaround risk, and the August 2026 guidance cut showed those risks are not theoretical.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CROX if you believe its drivers more; DKS if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CROX and DKS guides.

CROX. Even after a roughly 44% gain in 2026, Crocs trades near 11 times trailing and 8 times forward earnings, cheap for a business with mid-20s operating margins, because the market still questions how long single-product profitability lasts and how much HEYDUDE will cost. Analysts' mean target is about $138.75 across 12 covering firms. The October 29, 2026 Q3 report (consensus ~$1.0 billion revenue, $3.30 EPS) will show whether the second-quarter return to growth holds.

DKS. After the August reset DKS trades at roughly 11 times forward earnings and about 0.7 times sales, well below where it traded before the Foot Locker deal, which shows how much integration risk the market now prices in. Consensus looks for fiscal 2026 EPS of about $11.41, down roughly 14%, then a rebound of about 15% the following year. The next report, expected around November 24, 2026, has a consensus of about $1.37 per share on $5.07 billion of revenue, a seasonally weak quarter.

Headline figures (approximate, October 2026): CROX shows revenue (ttm) ~$4.05 billion; Q2 2026 ~$1.18 billion, up ~2.6% year over year, margins (ttm) Gross ~57%, operating ~24%, net ~15%, net income / eps (ttm) ~$593 million; trailing EPS ~$11.41, p/e (trailing / forward) ~10.9x / ~8.3x; DKS shows revenue (ttm) ~$21.2 billion; latest quarter up ~53% year over year including Foot Locker, q2 fiscal 2026 eps $3.53 vs ~$3.76 consensus (a miss); Q1 was $2.90 vs ~$2.91, margins (ttm) Gross ~33.1%, operating ~7.7%, net ~4.0%, net income (ttm) ~$839 million, down from ~$1.17 billion in fiscal 2024.

CROX and DKS are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CROX and DKS exposure against your real portfolio. It is not an investment adviser.